A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

1,538

Participants

Timeline

Start Date

March 1, 2011

Primary Completion Date

April 1, 2012

Study Completion Date

April 5, 2012

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

62.5/25mcg

GSK573719/GW64244

DRUG

62.5mcg

GSK573719

DRUG

25mcg

GW642444

DRUG

Placebo

Placebo

Trial Locations (165)

1000

GSK Investigational Site, Sofia

1202

GSK Investigational Site, Sofia

1431

GSK Investigational Site, Sofia

1501

GSK Investigational Site, Benoni

2113

GSK Investigational Site, Newtown

4000

GSK Investigational Site, Plovdiv

4001

GSK Investigational Site, Durban

5600

GSK Investigational Site, Troyan Municipality

5800

GSK Investigational Site, Pleven

6400

GSK Investigational Site, Dimitrovgrad

7000

GSK Investigational Site, Rousse

7130

GSK Investigational Site, Somerset West

7505

GSK Investigational Site, Tygerberg

7700

GSK Investigational Site, Mowbray

7764

GSK Investigational Site, Gatesville

9010

GSK Investigational Site, Varna

9301

GSK Investigational Site, Bloemfontein

10003

GSK Investigational Site, Cáceres

10330

GSK Investigational Site, Bangkok

10400

GSK Investigational Site, Bangkok

10538

GSK Investigational Site, Larchmont

11000

GSK Investigational Site, Nonthaburi

15009

GSK Investigational Site, Beaver

15706

GSK Investigational Site, Santiago de Compostela

16508

GSK Investigational Site, Erie

17190

GSK Investigational Site, Salt (gerona)

19460

GSK Investigational Site, Phoenixville

23249

GSK Investigational Site, Richmond

23606

GSK Investigational Site, Newport News

24210

GSK Investigational Site, Abingdon

28046

GSK Investigational Site, Madrid

28223

GSK Investigational Site, Pozuelo de Alarcón/Madrid

29303

GSK Investigational Site, Spartanburg

29340

GSK Investigational Site, Gaffney

29615

GSK Investigational Site, Greenville

29669

GSK Investigational Site, Pelzer

30046

GSK Investigational Site, Lawrenceville

30342

GSK Investigational Site, Atlanta

31008

GSK Investigational Site, Pamplona

32174

GSK Investigational Site, Ormond Beach

33603

GSK Investigational Site, Tampa

37601

GSK Investigational Site, Johnson City

38008

GSK Investigational Site, Santander

40002

GSK Investigational Site, Khon Kaen

41110

GSK Investigational Site, Larissa

42431

GSK Investigational Site, Madisonville

43215

GSK Investigational Site, Columbus

44100

GSK Investigational Site, Guadalajara

45040

GSK Investigational Site, Zapopan

45231

GSK Investigational Site, Cincinnati

45245

GSK Investigational Site, Cincinnati

45459

GSK Investigational Site, Dayton

46015

GSK Investigational Site, Valencia

47904

GSK Investigational Site, Lafayette

48903

GSK Investigational Site, Barakaldo (Vizcaya)

49601

GSK Investigational Site, Cadillac

50200

GSK Investigational Site, Chiang Mai

56429

GSK Investigational Site, Thessaloniki

57702

GSK Investigational Site, Rapid City

62100

GSK Investigational Site, Serres

63141

GSK Investigational Site, St Louis

64020

GSK Investigational Site, Monterrey

66061

GSK Investigational Site, Olathe

66606

GSK Investigational Site, Topeka

68134

GSK Investigational Site, Omaha

70115

GSK Investigational Site, New Orleans

70584

GSK Investigational Site, Sunset

71110

GSK Investigational Site, Heraklion, Crete

72000

GSK Investigational Site, Puebla, Pue

77030

GSK Investigational Site, Houston

77339

GSK Investigational Site, Kingwood

83814

GSK Investigational Site, Coeur d'Alene

85723

GSK Investigational Site, Tucson

87108

GSK Investigational Site, Albuquerque

90048

GSK Investigational Site, Los Angeles

90110

GSK Investigational Site, Songkhla

97504

GSK Investigational Site, Medford

119620

GSK Investigational Site, Moscow

123182

GSK Investigational Site, Moscow

150062

GSK Investigational Site, Yaroslavl

153000

GSK Investigational Site, Arkhangelsk

194354

GSK Investigational Site, Saint Petersburg

198260

GSK Investigational Site, Saint Petersburg

357538

GSK Investigational Site, Pyatigorsk

410028

GSK Investigational Site, Saratov

450071

GSK Investigational Site, Ufa

603126

GSK Investigational Site, Nizhny Novgorod

614077

GSK Investigational Site, Perm

630087

GSK Investigational Site, Novosibirsk

634063

GSK Investigational Site, Tomsk

660022

GSK Investigational Site, Krasnoyarsk

675000

GSK Investigational Site, Blagoveshchensk

2341131

GSK Investigational Site, Valparaíso

2570017

GSK Investigational Site, Viña del Mar

2841959

GSK Investigational Site, Rancagua

4270918

GSK Investigational Site, Talcahuano

8207257

GSK Investigational Site, Puente Alto - Santiago

8880465

GSK Investigational Site, Santiago

Unknown

GSK Investigational Site, Sofia

GSK Investigational Site, Santiago

GSK Investigational Site, Badalona / Barcelona

GSK Investigational Site, Centelles

T2N 4Z6

GSK Investigational Site, Calgary

R2K 3S8

GSK Investigational Site, Winnipeg

L7N 3V2

GSK Investigational Site, Burlington

L3M 1P3

GSK Investigational Site, Grimsby

N7T 4X3

GSK Investigational Site, Sarnia

M3H 5S4

GSK Investigational Site, Toronto

M5G 1N8

GSK Investigational Site, Toronto

M9W 4L6

GSK Investigational Site, Toronto

H2R 1V6

GSK Investigational Site, Montreal

H9R 3J1

GSK Investigational Site, Pointe-Claire

G1V 4G5

GSK Investigational Site, Québec

G3K 2P8

GSK Investigational Site, Québec

J6E 6J2

GSK Investigational Site, Saint-Charles-Borromée

G8T 7A1

GSK Investigational Site, Trois-Rivières

381 01

GSK Investigational Site, Český Krumlov

278 01

GSK Investigational Site, Kralupy nad Vltavou

697 33

GSK Investigational Site, Kyjov

410 02

GSK Investigational Site, Lovosice

741 01

GSK Investigational Site, Nový Jičín

772 00

GSK Investigational Site, Olomouc

301 00

GSK Investigational Site, Pilsen

150 00

GSK Investigational Site, Prague

153 00

GSK Investigational Site, Praha 5 - Radotin

337 01

GSK Investigational Site, Rokycany

415 10

GSK Investigational Site, Teplice

106 76

GSK Investigational Site, Athens

115 27

GSK Investigational Site, Athens

151 26

GSK Investigational Site, Athens

124 62

GSK Investigational Site, Haidari / Athens

546 42

GSK Investigational Site, Thessaloniki

963-8052

GSK Investigational Site, Fukushima

672-8064

GSK Investigational Site, Hyōgo

311-3193

GSK Investigational Site, Ibaraki

312-0057

GSK Investigational Site, Ibaraki

254-8502

GSK Investigational Site, Kanagawa

861-1196

GSK Investigational Site, Kumamoto

602-8026

GSK Investigational Site, Kyoto

530-0001

GSK Investigational Site, Osaka

558-8558

GSK Investigational Site, Osaka

343-8555

GSK Investigational Site, Saitama

690-8506

GSK Investigational Site, Shimane

690-8556

GSK Investigational Site, Shimane

103-0027

GSK Investigational Site, Tokyo

103-0028

GSK Investigational Site, Tokyo

158-0083

GSK Investigational Site, Tokyo

173-8610

GSK Investigational Site, Tokyo

85-681

GSK Investigational Site, Bydgoszcz

97-540

GSK Investigational Site, Gidle

86-300

GSK Investigational Site, Grudziądz

14-200

GSK Investigational Site, Iława

31-023

GSK Investigational Site, Krakow

10-357

GSK Investigational Site, Olsztyn

60-569

GSK Investigational Site, Poznan

71-124

GSK Investigational Site, Szczecin

01-456

GSK Investigational Site, Warsaw

18-400

GSK Investigational Site, Łomża

656 045

GSK Investigational Site, Barnaul

105 229

GSK Investigational Site, Moscow

0184

GSK Investigational Site, Meyerspark

03114

GSK Investigational Site, Alicante

08916

GSK Investigational Site, Badalona

07010

GSK Investigational Site, Palma de Mallorca

08830

GSK Investigational Site, Sant Boi de Llobregat - Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01313650 - A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD | Biotech Hunter | Biotech Hunter